The American College of Radiology Task Force on Breast Cancer published in 2003 the fourth edition of BI-RADS for Mammography. It is a lexicon of mammography terms including illustrations of each feature described, followed by a reporting format with assessment categories according to the degree of concern. The aim is to reduce inconsistencies in mammography reports and recommendations for assessment, to facilitate outcome monitoring and to allow each radiologist to audit his own mammography practice. In France, the Société Française de Radiologie acquired the rights to translate BI-RADS, word for word and without adaptation or influence. The last edition was published in 2004. Simultaneously, French Haute Autorité de Santé and National Committee for Breast Cancer Screening proposed to all community practice mammography facilities a classification of detected abnormalities stating more clearly than BI-RADS do which feature has to be included in such and such assessment category and how to manage it. This "classification ACR" is adapted from BI-RADS but strongly influenced by the context of the French nationwide screening programme, and by European recommendations to limitate undesirable risks of screening such as false positive and overdiagnosis. The differences between the two systems are discussed.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ejrad.2006.08.032 | DOI Listing |
Rev Med Interne
November 2023
Service de médecine interne, Centre de référence des maladies auto-immunes systémiques rares d'Île-de-France, hôpital Cochin, AP-HP, 27, rue du Faubourg-St-Jacques, 75014 Paris, France; Université Paris cité, 12, rue de l'École-de-Médecine, 75006 Paris, France. Electronic address:
Rev Med Interne
August 2023
Service de médecine interne et immunologie clinique, centre de référence maladies rares « maladies auto-immunes et auto-inflammatoires systémiques rares de l'adulte » (MAIS), CHU de Dijon Bourgogne, 2, boulevard Mal-de-Lattre-de-Tassigny, 21000 Dijon, France; Inserm, EFS BFC, UMR1098, RIGHT Interactions greffon-hôte-tumeur/ingénierie cellulaire et génique, université de Bourgogne, Dijon, France.
Rev Med Interne
December 2020
Département de médecine interne, Hôpital de la Timone, Assistance Publique-Hôpitaux de Marseille, Aix Marseille Université, Marseille, France. Electronic address:
The concept of IgG4-related disease (IgG4-RD) has recently been individualized in the early 2000s, but most of the organ involvements are known since more than 100 years. IgG4-RD is a non-malignant fibroinflammatory disorder, characterized by peculiar immunological and pathological abnormalities, which can affect virtually all organs or tissues. Diagnostic criteria have been proposed and have evolved rapidly, with general or organ specific criteria.
View Article and Find Full Text PDFRheumatology (Oxford)
May 2018
Departments of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Objectives: To validate the ACR-EULAR classification criteria for primary SS (pSS), and compare them to the American-European Consensus Group (AECG) and ACR criteria in a Dutch prospective diagnostic cohort.
Methods: Consecutive patients (n = 129) referred for suspicion of pSS underwent a multidisciplinary evaluation, including a labial and/or parotid gland biopsy. Patients with an incomplete work-up (n = 8) or associated systemic auto-immune disease (n = 7) were excluded.
Reumatologia
December 2016
Department of Systemic Connective Tissue Diseases, National Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland.
Systemic sclerosis is a complex disease characterized by autoimmunity, vasculopathy and tissue fibrosis. Although most patients present with some degree of skin sclerosis, which is a distinguishing hallmark, the clinical presentation vary greatly complicating the diagnosis. In this regard, new classification criteria were jointly published in 2013 by American College of Rheumatology (ACR) and European League Against Rheumatism (EULAR).
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!